Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rolapitant for Prevention of CINV in HEC
NCT01500213Phase 3Completed
- Start
- Feb 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rolapitant in chemotherapy-induced nausea and vomiting (CINV). Started Feb 2012; status: completed.
02
Drugs
rolapitant
03
Conditions
chemotherapy-induced nausea and vomiting (CINV)
Beyond the preview
Go deeper on NCT01500213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01500213.